RenovaCare, Inc. (RCAR)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
RenovaCare Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
87.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oriental Bioengineering | 121.58M |
| Infinity Pharmaceuticals | 2.57M |
| Gelesis Holdings | 12.14M |
| RVL Pharmaceuticals | 36.92M |
| Athersys | 80.00K |
| Genocea Biosciences | 1.91M |
| Marizyme | 183.42K |
| Seelos Therapeutics | 2.01M |
RenovaCare News
- 1 year ago - RenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc. - Business Wire
- 4 years ago - RenovaCare Announces Termination of StemCell Systems R&D Agreement - GlobeNewsWire
- 4 years ago - RenovaCare Announces Management Changes - GlobeNewsWire
- 4 years ago - RenovaCare Provides Clinical and Corporate Update - GlobeNewsWire
- 4 years ago - RM LAW Announces Investigation of RenovaCare, Inc. - PRNewsWire
- 5 years ago - RenovaCare Update - Newsfile Corp
- 5 years ago - BREAKING NEWS: TOP RANKED ROSEN LAW FIRM Encourages RenovaCare, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline - RCAR - PRNewsWire
- 5 years ago - RCAR INVESTOR NOTICE: Rosen Law Firm Encourages RenovaCare, Inc. Investors with Losses to Secure Counsel Before Important Deadline – RCAR - Business Wire